Hormone Optimization (HRT)

What Hormone Optimization Addresses

As men and women age, hormone levels naturally shift. For some, these changes contribute to symptoms that can affect energy, cognition, body composition, mood, and sexual health. Hormone optimization aims to restore levels to a more youthful, physiologically appropriate range (not supraphysiologic extremes) when lab results and clinical presentation indicate a deficiency.

Common concerns that may prompt evaluation include:

• Persistent fatigue or low motivation
• Brain fog, poor concentration, or memory lapses
• Unexplained weight gain, particularly central adiposity
• Loss of muscle mass or strength
• Low libido or sexual dysfunction
• Mood disturbances, irritability, or mild depression
• Sleep disruption or night sweats
• Hot flashes and vaginal dryness (in women)
• Erectile dysfunction or reduced morning erections (in men)

These symptoms are nonspecific and can have many causes. A thorough workup is essential before attributing them to hormone imbalance.

Hormone Optimization for Men

Testosterone levels in men decline gradually with age (age-related testosterone decline / clinical testosterone deficiency). When total testosterone is consistently low on repeat morning lab draws and accompanied by clinical symptoms, testosterone replacement therapy (TRT) may be considered.

Our approach:

• We measure total and free testosterone, SHBG, estradiol, LH, FSH, and a full metabolic panel before any treatment decision.
• We rule out other causes of symptoms, including thyroid dysfunction, sleep apnea, and nutritional deficiencies.
• If TRT is initiated, we use bioidentical testosterone (typically injectable or topical) dosed to maintain levels within the normal physiological range for a healthy young adult, not supraphysiologic levels.
• Follow-up labs are drawn at regular intervals to monitor testosterone, estradiol, hematocrit, and prostate-specific antigen (PSA) where indicated by age and risk profile.

We do not prescribe testosterone for men with normal age-adjusted levels solely for "anti-aging" purposes or athletic performance enhancement, and we do not accept requests for off-label performance use.

Hormone Optimization for Women

Perimenopause and menopause bring a decline in estradiol and progesterone that can cause vasomotor symptoms (hot flashes, night sweats), vaginal dryness, sleep disruption, and mood changes. Some women also experience a relative androgen deficiency that may affect libido and energy.

Our women's hormone optimization is grounded in:

• Comprehensive lab panels, including estradiol, progesterone, testosterone, DHEA-S, thyroid function, and adrenal markers.
• A symptom inventory and health history to contextualize lab values.
• Individualized treatment using bioidentical hormones (typically estradiol and progesterone) at the lowest effective doses to relieve symptoms while minimizing risk.
• For select women with documented low testosterone and persistent low libido after estrogen/progesterone optimization, we may consider low-dose testosterone therapy, with careful monitoring for virilizing side effects.

We do not prescribe unregulated compounded hormone pellets or supraphysiologic dosing protocols. All hormone prescriptions are written through licensed compounding pharmacies or commercial FDA-approved products, with clear documentation of active ingredients and doses. Note: Compounded bioidentical hormones are not FDA-approved and may carry unknown purity or strength risks; we discuss this distinction with every patient.

Lab & Bloodwork Screening

Objective data drives every decision. Before any hormone prescription, we require:

• Baseline labs: Comprehensive metabolic panel, complete blood count, lipid profile, thyroid panel (TSH, free T3, free T4), sex hormone levels (total and free testosterone, estradiol, progesterone, SHBG, LH, FSH, DHEA-S), PSA (men, where indicated), and additional markers as indicated (e.g., vitamin D, ferritin, cortisol). Blood pressure is recorded at baseline.
• Follow-up labs: After initiating therapy, labs are rechecked at 6-8 weeks, then at regular intervals (typically every 6 months once stable) to ensure hormone levels remain within safe, therapeutic ranges and to monitor for metabolic, hepatic, hematologic, and lipid changes. Cardiovascular parameters (blood pressure, lipid panel) are monitored for patients with cardiovascular risk factors.

We do not prescribe hormones based on symptom checklists or saliva testing alone. Objective serum levels and clinical context are required.

Who Is a Candidate

Hormone optimization may be appropriate for adults who:

• Have documented low hormone levels on repeat lab testing
• Experience moderate to severe symptoms that impair quality of life
• Have no contraindications to hormone therapy (see below)
• Are committed to regular follow-up labs and clinical visits
• Understand that treatment is part of a broader lifestyle and preventive medicine plan

Who is not a candidate

• Individuals with normal hormone levels seeking "enhancement" or performance gains
• Those with active or recent hormone-sensitive cancers (e.g., breast, prostate) without oncology clearance
• Patients with unexplained abnormal uterine bleeding
• Individuals with untreated severe sleep apnea, uncontrolled hypertension, or active thromboembolic disease
• Women who are pregnant, attempting pregnancy, or breastfeeding
• Anyone unwilling to undergo appropriate lab monitoring

Potential Benefits

When hormone levels are restored to an optimal physiological range, some patients report improvements in energy, mental clarity, mood stability, muscle strength, sexual desire and function, sleep quality, and body composition (with concurrent diet and exercise). Results vary and are not guaranteed; response depends on individual physiology, adherence to treatment, and lifestyle factors.

The clinical benefit of hormone therapy for non-menopausal, nonspecific symptoms (e.g., fatigue, brain fog) is not firmly established, and symptom improvement may reflect placebo effect or concurrent lifestyle changes. We do not claim that hormone optimization prevents chronic disease, reverses aging, or extends lifespan.

Risks & Contraindications

Hormone therapy carries risks that must be weighed carefully against potential benefits. We discuss these transparently with every patient.

General risks may include

• Fluid retention, acne, or skin changes
• Mood swings or irritability (often transient)
• Polycythemia (elevated red blood cell count) with testosterone therapy, which may increase clotting risk
• Changes in lipid profiles
• Potential impact on cardiovascular risk, where data remain mixed, so therapy should be individualized

Men

The FDA requires safety labeling addressing possible cardiovascular risk with testosterone products; potential risks also include acceleration of subclinical prostate cancer, testicular atrophy, reduced sperm production and infertility, and gynecomastia. Patients desiring future fertility should discuss alternatives.

Women

Estrogen-based therapy carries dose- and formulation-dependent risks that may include venous thromboembolism, stroke, cardiovascular events, and breast cancer with prolonged estrogen/progestin use; endometrial hyperplasia with unopposed estrogen; and virilization with excessive testosterone.

Absolute contraindications generally include

• Active or recent hormone-sensitive malignancy
• Pregnancy or breastfeeding
• Untreated severe hypertension
• Active liver disease
• History of thromboembolic events without adequate anticoagulation

All patients are screened for contraindications before therapy and monitored regularly. Any new symptoms or changes in health status must be reported promptly.